Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance

被引：18
|
作者：
Sanna, G
Bertolaccini, ML
Mameli, A
Hughes, GRV
Khamashta, MA [1 ]
Mathieu, A
机构：
[1] Kings Coll London, Sch Med, Lupus Res Unit, Rayne Inst, London, England
[2] Univ Cagliari, Cattedra Reumatol 2, Cagliari, Italy
[3] Homerton Univ, NHS Fdn Trust, Dept Rheumatol, London, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷 / 12期
关键词：
D O I：
10.1136/ard.2005.038430
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1795 / 1796
页数：2
相关论文
共 50 条
  • [1] Prevalence and clinical significance of antiphospholipid antibodies in patients with scleroderma.
    Bertolaccini, ML
    Sanna, G
    Mameli, A
    Khamashta, MA
    Mathieu, A
    Hughes, GRV
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S147 - S147
  • [2] ANTIPHOSPHOLIPID ANTIBODIES IN SCLERODERMA: PREVALENCE AND CLINICAL SIGNIFICANCE
    Bertolaccini, M. L.
    Sanna, G.
    Mameli, A.
    Khamashta, M. A.
    Mathieu, A.
    Hughes, G. R. V.
    [J]. RHEUMATOLOGY, 2002, 41 : 103 - 103
  • [3] Clinical significance of antiphospholipid antibodies in Indian scleroderma patients
    R. Gupta
    M. M. Thabah
    S. Gupta
    S. Shankar
    A. Kumar
    [J]. Rheumatology International, 2009, 30 : 277 - 279
  • [4] Clinical significance of antiphospholipid antibodies in Indian scleroderma patients
    Gupta, R.
    Thabah, M. M.
    Gupta, S.
    Shankar, S.
    Kumar, A.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2009, 30 (02) : 277 - 279
  • [5] ANTIPHOSPHOLIPID ANTIBODIES IN LUPUS PATIENTS WITH SEIZURES: PREVALENCE AND CLINICAL SIGNIFICANCE
    Sanna, G.
    Bertolaccini, M. L.
    Cuadrado, M. J.
    Khamashta, M. A.
    Hughes, G. R. V.
    [J]. RHEUMATOLOGY, 2003, 42 : 79 - 79
  • [6] Antiphospholipid antibodies in lymphoma: prevalence and clinical significance
    Pusterla, S
    Previtali, S
    Marziali, S
    Cortelazzo, S
    Rossi, A
    Barbui, T
    Galli, M
    [J]. HEMATOLOGY JOURNAL, 2004, 5 (04) : 341 - 346
  • [7] Prevalence and clinical significance of Antiphospholipid antibodies in lupus patients with seizures.
    Sanna, G
    Bertolaccini, ML
    Cuadrado, MJ
    Khamashta, MA
    Hughes, GRV
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S49 - S49
  • [8] The prevalence and clinical significance of IgA antiphospholipid antibodies (aPL)
    Shen, YP
    Dyszkiewicz-Korpanty, AM
    Lee, R
    Balani, J
    Frenkel, EP
    Sarode, R
    [J]. THROMBOSIS RESEARCH, 2004, 114 (5-6) : 637 - 637
  • [9] Antiphospholipid Antibodies in Systemic Sclerosis: Prevalence and Clinical Significance?
    Shetty, Anjali
    Volkov, Suncica
    Vergara, Claudia
    Swedler, William
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S749 - S750
  • [10] The prevalence and clinical significance of IgA Antiphospholipid antibodies (aPL).
    Shen, YM
    Dyszkiewicz-Korpanty, A
    Lee, R
    Balani, J
    Frenkel, E
    Sarode, R
    [J]. BLOOD, 2005, 106 (11) : 743A - 743A
12345